A comparison of the cost-effectiveness of HPV (self-sampling and health care provider sampling) versus VIA for cervical cancer screening in India
Abstract
Cervical cancer ranks as the fourth most common cancer in women globally and the second most prevalent in India. Preventive measures, such as HPV vaccination and various screening methods, are essential. Despite these strategies, the economic burden of cervical cancer remains significant due to its long-term nature and treatment costs. This study evaluates the cost-effectiveness of three screening approaches-VIA, HPV physician sampling, and HPV self-sampling-for women aged 30 to 65. A Markov-based cost-utility analysis with a lifetime horizon and one-year cycle length was conducted. Model parameters were sourced from peer-reviewed literature, national cancer registries, and health economic studies. Deterministic and probabilistic sensitivity analyses were performed to ensure the robustness of the results. Health Provider HPV sampling yielded the highest Quality-Adjusted Life Years (QALYs) at 5.97 (three years) and 4.28 (five years), compared to VIA's 4.01 (three years) and 2.9 (five years), and HPV self-sampling's 4.71 (three years) and 3.41 (five years). Over 30 cycles for 100,000 women, healthcare provider sampling achieved a maximum QALY gain of 13.40. Compared to other methods, it offered a gain of 2.94 QALYs at an incremental cost of 19,409 INR. While VIA screening is cost-saving, it provides reduced health benefits. HPV healthcare provider sampling is more cost-effective in terms of QALYs gained despite higher screening costs. A policy analysis is necessary to achieve 70% cervical cancer screening coverage in India, focusing on current HPV screening strategies and identifying areas for improvement.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064 · see citing works
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648 · see citing works
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810 · see citing works
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278 · see citing works
Cancer incidence estimates for 2022 & projection for 2025
Sathishkumar, K., Chaturvedi, M., Das, P., Stephen, S., & Mathur, P. (2022) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1821_22 · Cited by 866 · see citing works
Probabilistic Sensitivity Analysis Using Monte Carlo Simulation: A Practical Approach
Doubilet, P., Begg, C. B., Weinstein, M. C., Braun, P., & McNeil, B. J. (1985) · Medical Decision Making · doi:10.1177/0272989x8500500205 · Cited by 860 · see citing works
Arbyn, M., Smith, S. B., Temin, S., Sultana, F., & Castle, P. (2018) · BMJ · doi:10.1136/bmj.k4823 · Cited by 851 · see citing works
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.10.008 · Cited by 847 · see citing works
A review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747 · see citing works
Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010166 · Cited by 470 · see citing works
Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
Mandelblatt, J. S. (2002) · JAMA · doi:10.1001/jama.287.18.2372 · Cited by 302 · see citing works
Burden of cervical cancer and role of screening in India
Bobdey, S., Sathwara, J., Jain, A., & Balasubramaniam, G. (2016) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.195751 · Cited by 254 · see citing works
Sankaranarayanan, R., Prabhu, P. R., Pawlita, M., Gheit, T., Bhatla, N., Muwonge, R., Nene, B. M., Esmy, P. O., Joshi, S., Poli, U. R. R., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00414-3 · Cited by 242 · see citing works
Mustafa, R. A., Santesso, N., Khatib, R., Mustafa, A. A., Wiercioch, W., Kehar, R., Gandhi, S., Chen, Y., Cheung, A., Hopkins, J., et al. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.07.024 · Cited by 199 · see citing works
Screening for Cervical Cancer in Primary Care
Kim, J. J., Burger, E. A., Regan, C., & Sy, S. (2018) · JAMA · doi:10.1001/jama.2017.19872 · Cited by 170 · see citing works
Kazibwe, J., Gheorghe, A., Wilson, D., Ruiz, F., Chalkidou, K., & Chi, Y.-L. (2022) · Value in Health · doi:10.1016/j.jval.2021.08.014 · Cited by 139 · see citing works
Gravitt, P. E., Paul, P., Katki, H. A., Vendantham, H., Ramakrishna, G., Mrudula, S., Basany, K., Ronnett, B. M., Vijayaraghavan, K., Shah, K. V., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013711 · Cited by 136 · see citing works
National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison
Sharma, D., Aggarwal, A. K., Downey, L. E., & Prinja, S. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-020-00250-7 · Cited by 114 · see citing works
Simms, K. T., Keane, A., Nguyen, D. T. N., Caruana, M., Hall, M. T., Lui, G., Gauvreau, C., Demke, O., Arbyn, M., Basu, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02600-4 · Cited by 105 · see citing works
Cost-effectiveness studies of HPV self-sampling: A systematic review
Malone, C., Barnabas, R. V., Buist, D. S. M., Tiro, J. A., & Winer, R. L. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105953 · Cited by 102 · see citing works
Cost effectiveness of strategies for cervical cancer prevention in India
Chauhan, A. S., Prinja, S., Srinivasan, R., Rai, B., Malliga, J., Jyani, G., Gupta, N., & Ghoshal, S. (2020) · PLOS ONE · doi:10.1371/journal.pone.0238291 · Cited by 75 · see citing works
Legood, R., Gray, A. M., Mahé, C., Wolstenholme, J., Jayant, K., Nene, B. M., Shastri, S. S., Malvi, S. G., Muwonge, R., Budukh, A. M., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21220 · Cited by 71 · see citing works
Adsul, P., Manjunath, N., Srinivas, V., Arun, A., & Madhivanan, P. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.06.008 · Cited by 63 · see citing works
Morgan, K., Azzani, M., Khaing, S. L., Wong, Y.-L., & Su, T. T. (2019) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000476 · Cited by 53 · see citing works
Nath, A., Shalini, M., & Mathur, P. (2021) · The National Medical Journal of India · doi:10.4103/0970-258x.323661 · Cited by 46 · see citing works
Self-citationSawaya, G. F., Sanstead, E. C., Alarid‐Escudero, F., Smith‐McCune, K., Gregorich, S. E., Silverberg, M. J., Leyden, W. A., Huchko, M. J., Kuppermann, M., & Kulasingam, S. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0299 · Cited by 43 · see citing works
Kelly, H. A., Jaafar, I., Chung, M. H., Michelow, P. M., Greene, S. A., Strickler, H. D., Xie, X., SCHIFFMAN, M. H., Broutet, N. J. N., Mayaud, P., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101645 · Cited by 42 · see citing works
The who-choice cost-effectiveness Threshold: a Country-level analysis of changes over time
Griffiths, M., Maruszczak, M. J., & Kusel, J. (2015) · Value in Health · doi:10.1016/j.jval.2015.03.517 · Cited by 32 · see citing works
Mekuria, S. F., Timmermans, S., Borgfeldt, C., Jerkeman, M., Johansson, P., & Linde, D. S. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02252-y · Cited by 32 · see citing works
Chary, A. N., & Rohloff, P. J. (2014) · Global Health Science and Practice · doi:10.9745/ghsp-d-14-00073 · Cited by 31 · see citing works
Telemedicine and Cancer Care in India: Promises, Opportunities and Caveats
Deo, S. V. S., Pramanik, R., Chaturvedi, M., Nath, A., Ghosh, J., Majumdar, S. K. D., Salins, N. S., Kadayaprath, G., Garg, P. K., Chaturvedi, A., et al. (2022) · Future Science OA · doi:10.2144/fsoa-2022-0001 · Cited by 29 · see citing works
Self-citationChaturvedi, M., Sathishkumar, K., Sudarshan, K. L., Nath, A., Das, P., & Mathur, P. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102248 · Cited by 27 · see citing works
Self-citationBains, I., Choi, Y. H., Soldan, K., & Jit, M. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2018-000161 · Cited by 24 · see citing works
Hariprasad, R., John, A., & Abdulkader, R. S. (2023) · JCO Global Oncology · doi:10.1200/go.22.00401 · Cited by 20 · see citing works
Bogale, A. L., Teklehaymanot, T., Kassie, G. M., Medhin, G., Haidar, J., & Berhe, N. B. (2022) · Cancer Control · doi:10.1177/10732748221114980 · Cited by 11 · see citing works
Human Papillomaviruses and Cancer
(n.d.) · PsycEXTRA Dataset · doi:10.1037/e309762004-001
Flagged first, then by citations
Research works printed but not linked: 2
- Kim, 2018, Screening for cervical cancer in primary care: a decision analysis for the US preventive services task force, Jama, 320, 706, 10.1001/jama.2017.19872 · DOI
- Bray, 2024, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 74, 229
Cited by
Still being checked.
- Authors
- Pant, A., Thangavel, G., Mathew, S., & Nath, A.
- Affiliations
- Indian Council of Medical Research (IN)
- Corresponding author
- Nath, Anita
- Venue
- Journal of Cancer Policy
- Publisher
- Elsevier BV
- Published
- 2025-12
- Volume
- 46
- Pages
- 100642
- ISSN
- 2213-5383 (ISSN-L)
- OpenAlex
- W4414382594
- Semantic Scholar
- 2cf347f027fab3adf0db67d13d0407a52e2a5c72
- Cited by
- 2
- References
- 36
- Citations by year
- 2026: 1 · 2025: 1
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Cancer Policy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Health and Family Welfare
- Department of Health Research
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- cervical cancer screening, HPV self-sampling, visual inspection with acetic acid, cost-effectiveness, quality-adjusted life years, Markov model, India, screening coverage
- MeSH terms
- Adult, Aged, Uterine Cervical Neoplasms, Cost-Benefit Analysis, Female, Health Personnel, Humans, India, Mass Screening, Middle Aged, Vaginal Smears, Quality-Adjusted Life Years, Papillomaviridae, Papillomavirus Infections, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
